Skip to main content
All lobbying filings

THE METROHEALTH SYSTEM

Lobbying for THE METROHEALTH SYSTEM

 Filing 4th Quarter - Amendment
4th Quarter (Oct 1 - Dec 31) 2025 · Ohio · House · Senate · $230,000.00 expenses · posted Jan 20, 2026

Official filing document

 Bills named in this filing 23
  • HR 8574
    U.S. in Expos Act
  • HR 7053
    Preemption of Real Property Discrimination Act
  • S 3792
    Water Project Navigators Act
  • HR 1613
    Protecting Mushroom Farmers Act
  • HR 2665
    Trade Review Act of 2025
  • HR 3561
    FORCE Act
  • HR 3290
    National Museum of Pop Culture Act
  • HR 5378
    Tribal Healthcare Careers Act
  • HR 5860
    SNAP BACK Act.
  • S 3548
    Fair Competition for Small Business Act of 2025
  • HR 6363
    Build Now Act of 2025
  • HR 2872
    RESILIENCE Act of 2025
  • HR 7463
    Foster Youth Postsecondary Education Access and Success Act
  • HR 7327
    Empowering Young Readers Act of 2026
  • S 3450
    Emergency Response Authority Act
  • HR 4390
    U.S. Diplomatic Posture Review Act of 2025
  • HR 3281
    To prohibit the reduction, elimination, or suspension of funding for land-grant colleges and universities.
  • HR 4392
    Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
  • HR 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HR 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
  • HR 10545
    American Relief Act, 2025
  • HR 10337
    Expanding the Health Care Workforce Act
 Lobbying activity 4
Pharmacy

H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.

Medicare/Medicaid

Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.

Health Issues

Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.

Budget/Appropriations

H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem